Author
Listed:
- Daniel A. Kuppers
(Fred Hutchinson Cancer Research Center)
- Sonali Arora
(Fred Hutchinson Cancer Research Center)
- Yiting Lim
(Fred Hutchinson Cancer Research Center)
- Andrea R. Lim
(Fred Hutchinson Cancer Research Center
University of Washington)
- Lucas M. Carter
(Fred Hutchinson Cancer Research Center)
- Philip D. Corrin
(Fred Hutchinson Cancer Research Center)
- Christopher L. Plaisier
(Arizona State University)
- Ryan Basom
(Fred Hutchinson Cancer Research Center)
- Jeffrey J. Delrow
(Fred Hutchinson Cancer Research Center)
- Shiyan Wang
(Princess Margaret Cancer Centre/University Health Network)
- Housheng Hansen He
(Princess Margaret Cancer Centre/University Health Network)
- Beverly Torok-Storb
(Fred Hutchinson Cancer Research Center)
- Andrew C. Hsieh
(Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
University of Washington)
- Patrick J. Paddison
(Fred Hutchinson Cancer Research Center)
Abstract
Many of the regulatory features governing erythrocyte specification, maturation, and associated disorders remain enigmatic. To identify new regulators of erythropoiesis, we utilize a functional genomic screen for genes affecting expression of the erythroid marker CD235a/GYPA. Among validating hits are genes coding for the N6-methyladenosine (m6A) mRNA methyltransferase (MTase) complex, including, METTL14, METTL3, and WTAP. We demonstrate that m6A MTase activity promotes erythroid gene expression programs through selective translation of ~300 m6A marked mRNAs, including those coding for SETD histone methyltransferases, ribosomal components, and polyA RNA binding proteins. Remarkably, loss of m6A marks results in dramatic loss of H3K4me3 marks across key erythroid-specific KLF1 transcriptional targets (e.g., Heme biosynthesis genes). Further, each m6A MTase subunit and a subset of their mRNAs targets are required for human erythroid specification in primary bone-marrow derived progenitors. Thus, m6A mRNA marks promote the translation of a network of genes required for human erythropoiesis.
Suggested Citation
Daniel A. Kuppers & Sonali Arora & Yiting Lim & Andrea R. Lim & Lucas M. Carter & Philip D. Corrin & Christopher L. Plaisier & Ryan Basom & Jeffrey J. Delrow & Shiyan Wang & Housheng Hansen He & Bever, 2019.
"N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis,"
Nature Communications, Nature, vol. 10(1), pages 1-17, December.
Handle:
RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-12518-6
DOI: 10.1038/s41467-019-12518-6
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-12518-6. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.